5-chloro-3-methyl-4-nitro-1H-pyrazole: abscission agent for loosening citrus fruit before harvesting; do not confuse with triclopyr [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Citrus | genus | A plant genus of the family RUTACEAE. They bear the familiar citrus fruits including oranges, grapefruit, lemons, and limes. There are many hybrids which makes the nomenclature confusing.[MeSH] | Rutaceae | A plant family in the order Sapindales that grows in warmer regions and has conspicuous flowers.[MeSH] |
| ID Source | ID |
|---|---|
| PubMed CID | 23256 |
| SCHEMBL ID | 13866122 |
| SCHEMBL ID | 2549734 |
| MeSH ID | M0069800 |
| Synonym |
|---|
| STL300009 |
| release |
| 1h-pyrazole, 3-chloro-5-methyl-4-nitro- |
| caswell no. 196a |
| pyrazole, 3(or 5)-chloro-5(or 3)-methyl-4-nitro- |
| abg 3030 |
| 5-chloro-3-methyl-4-nitropyrazole |
| epa pesticide chemical code 207100 |
| 3-chloro-5-methyl-4-nitro-1h-pyrazole |
| brn 0005657 |
| FT-0664771 |
| AKOS005266810 |
| pyrazachlor |
| 6814-58-0 |
| cmn pyrazole |
| unii-n8uw78c99u |
| 4-23-00-00591 (beilstein handbook reference) |
| cmnp |
| 5-chloro-3-methyl-4-nitro-1h-pyrazole |
| n8uw78c99u , |
| AKOS013433806 |
| PB15692 |
| 3(or 5)-chloro-5(or 3)-methyl-4-nitropyrazole |
| DTXSID3058454 |
| SCHEMBL13866122 |
| SCHEMBL2549734 |
| chloro-3-methyl-4-nitro-1h-pyrazole, 5- |
| GS-5686 |
| mfcd00462202 |
| CS-0050522 |
| AKOS034830301 |
| AMY4079 |
| Q27284715 |
| SY042202 |
| EN300-113594 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.33) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||